Related Experiment Video
Updated: Sep 17, 2025

Identifying Dysregulated Genes Induced by Kaposi's Sarcoma-associated Herpesvirus KSHV
Published on: September 14, 2010
Viral associations with hematologic cancers
Mark Stasiewicz1, Tomasz M Karpiński2
1Department of Internal Medicine, Kirk Kerkorian School of Medicine at UNLV, 1701 W Charleston Blvd Suite 250, Las Vegas, NV, 89102, USA.
Insights
Viruses are a major cause of hematologic malignancies (HMs). This review details key viruses linked to HMs, their mechanisms, and management strategies for clinicians.
Area of Science:
- Oncology
- Virology
- Hematology
Background:
- Hematologic malignancies (HMs) represent a significant global health burden, with over one million new cases in 2020.
- Infectious agents, particularly viruses, are recognized as significant contributors to oncogenesis in hematologic cancers.
- Understanding viral associations is crucial for managing HMs and preventing complications.
Purpose of the Study:
- To review the current understanding of viral associations with hematologic malignancies.
- To identify key viruses implicated in HM development and their oncogenic mechanisms.
- To provide an overview of current management principles for virus-associated HMs.
Main Methods:
- A comprehensive literature search of the PubMed database was conducted.
- The review focused on identifying evidence linking specific viruses to hematologic malignancies.
- Information on oncogenic mechanisms and clinical management was synthesized.
Main Results:
- Epstein-Barr virus, human immunodeficiency virus, human T-lymphotropic virus, hepatitis C virus, and Kaposi sarcoma herpesvirus show strong evidence of association with HMs.
- Reactivation of latent hepatitis B virus is a concern during HM treatment regimens.
- Mechanisms of viral oncogenesis and current management strategies are summarized.
Conclusions:
- Viruses play a critical role in the etiology of many hematologic malignancies.
- Clinicians can utilize this information to determine malignancy etiology and implement preventive strategies.
- Effective management requires addressing both the malignancy and the associated viral factors.
Abstract:
Hematologic malignancies (HMs) continue to present a burden upon healthcare systems worldwide, with over one million incident cases reported in 2020 alone. It has been known for decades that infectious agents serve as the etiologic agents for a number of neoplastic disorders and outright cancers. Viruses are the predominant infectious contributor to oncogenesis among HMs. The PubMed database was utilized to outline the present state of understanding as it relates to viral associations with HMs. Viruses with the most evidence supporting their association with the development of HMs include Epstein-Barr virus, human immunodeficiency virus, human T-lymphotropic virus, hepatitis C virus and Kaposi sarcoma herpesvirus. Reactivation of latent hepatitis B virus is associated with treatment regimens commonly used in the management of HMs. Furthermore, brief summaries of the oncogenic mechanisms underlying the aforementioned associations and an overview of current management principles are presented. Such information may serve to guide clinicians in establishing the etiology of their patients' malignancy and help establish best practices to prevent the spread and reactivation of viruses associated with the development and treatment of HMs.
More Related Videos
08:52Generation of Multivirus-specific T Cells to Prevent/treat Viral Infections after Allogeneic Hematopoietic Stem Cell Transplant
Published on: May 27, 2011
11:18Expanding Cytotoxic T Lymphocytes from Umbilical Cord Blood that Target Cytomegalovirus, Epstein-Barr Virus, and Adenovirus
Published on: May 7, 2012
Related Concept Videos
Mechanisms of Retrovirus-induced Cancers
Rous Sarcoma Virus (RSV) and Cancer
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
Role of Hematopoietic Growth Factors
Thrombopoietin (TPO), mainly released by the liver,...
Immunodeficiency Diseases
There are three main causes of immunodeficiency...
Hematopoiesis
Regulation of Hematopoietic Stem Cells